
NextMed Health: The Future of Health and Medicine
Event Date: March 30, 2025. BioAstra co-founder Chris Mason will be speaking at NextMed Health 2025 – a unique interdisciplinary…
VIEW MORE
For most of its history, human spaceflight has been defined by engineering achievement: propulsion, life support, materials science, and orbital mechanics. Rockets, not biology, were the constraint. While reaching deep space still requires stellar engineering, as missions extend in duration and ambition, the limiting variables are increasingly biological.
Any astronaut will tell you a mission to space is a profound experience. At the biological level, it is accompanied by measurable changes.
Microgravity temporarily alters gene expression and cellular signaling in ways scientists are still working to fully understand. Radiation exposure affects DNA repair and long-term disease risk. Immune dysregulation emerges during extended missions, and drug absorption and metabolism shift in altered physiological states. These are not secondary considerations. They define the limits of sustainable human presence beyond Earth while also revealing biological mechanisms difficult to isolate under terrestrial conditions.
Space health cannot advance through aerospace engineering alone. It requires deep biomedical and biotech expertise applied directly to space-specific biological problems. Genetics, pharmacology, systems biology, and bioinformatics are not adjacent to space health. They are central to the next phase of human spaceflight, which depends on integrating scientists prepared to apply these disciplines within the realities of space environments.
Moving biomedical research into space isn’t as simple as asking the same questions in a different environment. The environment fundamentally changes how those questions are designed and tested.
Terrestrial biomedical research benefits from scale, controlled variables, and iterative refinement. Experiments are repeated, then replicated, and repeated again. That is a core tenet of the scientific method. In space, those assumptions break down. Sample sizes are limited, experimental windows are finite, conditions cannot always be replicated or fully controlled, and failure is expensive.
The reality is simple: you don’t get multiple shots. Experiments have to be right before they leave the ground, because once they’re in space, there is very little room to fix what doesn’t work.
Translational health technologies require more than domain expertise. Biomedical training develops depth within defined disciplines such as genetics, pharmacology, and computational biology. Most scientists spend years becoming experts in increasingly specialized questions. In space-specific environments, that depth must be paired with systems awareness and a willingness to work across biological, operational, and institutional boundaries.
Those who can integrate domain knowledge with contextual awareness will help shape the next phase of the field.
At BioAstra, we designed the 2026 Research Fellowship (Crew-4) to implement this philosophy. It is structured to embed fellows within active, principal investigator–led research aligned with conference and publication pathways. Fellows contribute to work spanning genomics, pharmacological modeling, computational biology, and translational countermeasure development, and will work within the operational timelines and collaborative structures that define human spaceflight research. The fellowship emphasizes measurable scientific contribution aligning domain expertise with aerospace context.
BioAstra Research Fellows make up a vital connective infrastructure between traditionally non-aerospace biomedical domains and the space-specific biological challenges shaping the future of human spaceflight.
As human spaceflight expands, the responsibility to ensure its scientific progress benefits people on Earth grows alongside it. Discoveries made in space should not remain confined to missions and laboratories. They should advance our understanding of biology and contribute to improving health outcomes for communities everywhere.
If you are a biomedical scientist interested in applying your expertise to the challenges of human spaceflight, we encourage you to apply to BioAstra’s 2026 Research Fellowship (Crew-4) and help shape the future of translational space health.
Applications close April 30 → Apply now to join Crew-4

Event Date: March 30, 2025. BioAstra co-founder Chris Mason will be speaking at NextMed Health 2025 – a unique interdisciplinary…
VIEW MORE

Event Date: March 7, 2025. Join BioAstra leadership at SXSW to talk about all things future and all things health…
VIEW MORE

This is important: Space exploration isn’t about escaping the challenges of Earth or simply satisfying our curiosity for the unknown.…
VIEW MORE
